Brett Monia, Ionis CEO

Up­dat­ed: Roche, Io­n­is launch new Hunt­ing­ton’s dis­ease study

SAN FRAN­CIS­CO — A new study for the Hunt­ing­ton’s dis­ease drug tomin­ersen, de­vel­oped in tan­dem by Roche and Io­n­is, “is open and has start­ed screen­ing el­i­gi­ble …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.